Disc Medicine, Inc. Quarterly Income Tax Expense (Benefit) in USD from Q2 2022 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Disc Medicine, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q2 2022 to Q3 2024.
  • Disc Medicine, Inc. Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $114K, a 470% increase year-over-year.
  • Disc Medicine, Inc. Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $211K.
  • Disc Medicine, Inc. annual Income Tax Expense (Benefit) for 2023 was $99K.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $211K $114K +$94K +470% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $117K $60K +$36K +150% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $81K $5K -$18K -78.3% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $99K $32K Oct 1, 2023 Dec 31, 2023 10-K 2024-03-21
Q3 2023 $20K +$20K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $24K +$24K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $23K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q3 2022 $0 Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $0 Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.